Liraglutide probably the best second drug to prevent cardiovascular events in patients with T2DM who take metformin

Liraglutide probably the best second drug to prevent cardiovascular events in patients with T2DM who take metformin is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or .

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

There's more to see -- the rest of this topic is available only to subscribers.